tiprankstipranks
Trending News
More News >
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541)
:1541
Hong Kong Market

Compare ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) vs. Competitors

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
HK$6.15
HK$5.16B
-7.61
22.24%
Ascletis Pharma, Inc.
HK$12.33
HK$12.49B
-44.18
311.44%
1 Buy
1 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$9.91B
-47.34
123.11%
1 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$14.25B
99.64
381.23%
CStone Pharmaceuticals
HK$5.34
HK$8.41B
-18.58
163.18%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$8.87
HK$5.90B
153.40
12.59%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
6.32
1.72
37.39%
HK:1672
Ascletis Pharma, Inc.
12.59
9.41
295.91%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.33
3.06
134.80%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
35.90
28.21
366.84%
HK:2616
CStone Pharmaceuticals
5.79
3.70
177.03%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
9.48
0.79
9.09%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts